Paper Summary
Identifying Elevated Neuroinflammatory Proteomic Markers in Cerebrospinal Fluid From COVID-19

In an article published in BMC Neurology, Shelli Farhadian and her Yale School of Medicine colleagues utilized IsoPlexis’ technology to research the case of a SARS-CoV-2 positive patient who initially presented with neurological rather than respiratory symptoms.

Download Resource

Your Data is Secure

We will always keep your personal information safe and not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.

In this Paper Summary we discuss:
  • Case presentation: neuroinflammation due to COVID-19
  • Functional proteomics reveals mechanisms in a new clinical presentation for COVID-19
  • Proteomic markers for neuroinflammation in COVID-19

Identifying Elevated Neuroinflammatory Proteomic Markers in Cerebrospinal Fluid From COVID-19

In an article published in BMC Neurology, Shelli Farhadian and her Yale School of Medicine colleagues utilized IsoPlexis' technology to research the case of a SARS-CoV-2 positive patient who initially presented with neurological rather than respiratory symptoms.

IsoPlexis Awards